Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
national blog main
san francisco blog main
5
×
boston blog main
life sciences
national top stories
san francisco top stories
boston top stories
new york blog main
startups
deals
detroit blog main
detroit top stories
new york top stories
raleigh-durham blog main
san francisco
wisconsin blog main
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alphabet
alzheimer's
ameet nathwani
arboretum ventures
arches
aurora health care
azacitidine
baird capital
beta-thalassemia
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of harvard and mit
brook byers
cancer
cancer diagnostics
charles chu
crispr
What
based
5
×
bio
company
developing
medicine
startup
step
week
aims
american
ann
announced
approach
arbor
area
available
bay
best
big
biopsy
biosciences
biotech
blood
buildout
called
cancer
cas
cheaper
close
closed
continue
crash
crispr
debate
debuts
develop
diagnostics
drugs
epigenetic
epigenetics
Language
unset
Current search:
biotech
×
based
×
" san francisco blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
